When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine.
This report contains market size and forecasts of mRNA Vaccines in Global, including the following market information:
Global mRNA Vaccines Market Size 2024-2030, ($ millions)
The global mRNA Vaccines market is projected to reach US$ million by 2029.
We surveyed the mRNA Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines Market, by Type, 2024-2030 ($ millions)
Global mRNA Vaccines Market Segment Percentages, by Type
Being Developed
Preclinical
Clinical I
Clinical II
Global mRNA Vaccines Market, by Application, 2024-2030 ($ millions)
Global mRNA Vaccines Market Segment Percentages, by Application
COVID-19
Cancer
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Global mRNA Vaccines Market, By Region and Country, 2024-2030 ($ Millions)
Global mRNA Vaccines Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
MODERNA
Pfizer
Zydus Cadila
Fosun Pharmaceutical
CureVac
Stemirna
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines Overall Market Size
2.1 Global mRNA Vaccines Market Size: 2023 VS 2030
2.2 Global mRNA Vaccines Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key mRNA Vaccines Players in Global Market
3.2 Global Companies mRNA Vaccines Product & Technology
4 mRNA Vaccines Companies Profiles
4.1 MODERNA
4.1.1 MODERNA Company Summary
4.1.2 MODERNA Business Overview
4.1.3 MODERNA mRNA Vaccines Product Offerings & Technology
4.1.4 MODERNA mRNA Vaccines R&D, and Plans
4.2 Pfizer
4.2.1 Pfizer Company Summary
4.2.2 Pfizer Business Overview
4.2.3 Pfizer mRNA Vaccines Product Offerings & Technology
4.2.4 Pfizer mRNA Vaccines R&D, and Plans
4.3 Zydus Cadila
4.3.1 Zydus Cadila Company Summary
4.3.2 Zydus Cadila Business Overview
4.3.3 Zydus Cadila mRNA Vaccines Product Offerings & Technology
4.3.4 Zydus Cadila mRNA Vaccines R&D, and Plans
4.4 Fosun Pharmaceutical
4.4.1 Fosun Pharmaceutical Company Summary
4.4.2 Fosun Pharmaceutical Business Overview
4.4.3 Fosun Pharmaceutical mRNA Vaccines Product Offerings & Technology
4.4.4 Fosun Pharmaceutical mRNA Vaccines R&D, and Plans
4.5 CureVac
4.5.1 CureVac Company Summary
4.5.2 CureVac Business Overview
4.5.3 CureVac mRNA Vaccines Product Offerings & Technology
4.5.4 CureVac mRNA Vaccines R&D, and Plans
4.6 Stemirna
4.6.1 Stemirna Company Summary
4.6.2 Stemirna Business Overview
4.6.3 Stemirna mRNA Vaccines Product Offerings & Technology
4.6.4 Stemirna mRNA Vaccines R&D, and Plans
5 Sights by Region
5.1 By Region - Global mRNA Vaccines Market Size, 2024 & 2030
5.2 By Region - Global mRNA Vaccines Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of mRNA Vaccines in United States
5.3.2 United States mRNA Vaccines Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of mRNA Vaccines in Europe
5.4.2 Europe mRNA Vaccines Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of mRNA Vaccines in China
5.5.2 China mRNA Vaccines Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global mRNA Vaccines Market Size Markets, 2024 & 2030
6.2 Being Developed
6.3 Preclinical
6.4 Clinical I
6.5 Clinical II
7 Sights by Application
7.1 By Application - Global mRNA Vaccines Market Size, 2024 & 2030
7.2 COVID-19
7.3 Cancer
7.4 Infectious Disease Treatment MRNA Vaccine
7.5 Infection Prevention MRNA Vaccine
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. mRNA Vaccines Market Opportunities & Trends in Global Market
Table 2. mRNA Vaccines Market Drivers in Global Market
Table 3. mRNA Vaccines Market Restraints in Global Market
Table 4. Key Players of mRNA Vaccines in Global Market
Table 5. Global Companies mRNA Vaccines Product & Technology
Table 6. MODERNA Company Summary
Table 7. MODERNA mRNA Vaccines Product Offerings
Table 8. Pfizer Company Summary
Table 9. Pfizer mRNA Vaccines Product Offerings
Table 10. Zydus Cadila Company Summary
Table 11. Zydus Cadila mRNA Vaccines Product Offerings
Table 12. Fosun Pharmaceutical Company Summary
Table 13. Fosun Pharmaceutical mRNA Vaccines Product Offerings
Table 14. CureVac Company Summary
Table 15. CureVac mRNA Vaccines Product Offerings
Table 16. Stemirna Company Summary
Table 17. Stemirna mRNA Vaccines Product Offerings
Table 18. By Region? Global mRNA Vaccines Revenue, (US$, Mn), 2024 & 2030
Table 19. By Region - Global mRNA Vaccines Revenue, (US$, Mn), 2024-2030
Table 20. By Type ? Global mRNA Vaccines Market Size, (US$, Mn), 2024 & 2030
Table 21. By Application? Global mRNA Vaccines Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. mRNA Vaccines Segment by Type in 2030
Figure 2. mRNA Vaccines Segment by Application in 2030
Figure 3. Global mRNA Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global mRNA Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global mRNA Vaccines Revenue Market Share, 2024-2030
Figure 8. By Type - Global mRNA Vaccines Revenue Market Share, 2024-2030
Figure 9. By Application - Global mRNA Vaccines Revenue Market Share, 2024-2030
